Yes, Functional Imaging (Including Lexiscan Stress Testing) Is Recommended After Equivocal Coronary CTA
When coronary CTA is equivocal or non-diagnostic, functional imaging for myocardial ischemia—including regadenoson (Lexiscan) stress testing—is the recommended next step to clarify findings and determine the functional significance of any detected coronary artery disease. 1
The Guideline-Based Approach
The most recent European Society of Cardiology guidelines (2019) provide clear direction: functional imaging for myocardial ischemia is recommended (Class I, Level B) if coronary CTA has shown CAD of uncertain functional significance or is not diagnostic 1. This represents the strongest level of recommendation based on solid evidence.
Similarly, the 2021 ACC/AHA chest pain guidelines state that for patients with an inconclusive CCTA, stress imaging (with echocardiography, PET/SPECT MPI, or CMR) can be useful for the diagnosis of myocardial ischemia 2, 3. The guidelines also note that coronary CTA should be considered as an alternative to invasive angiography if another non-invasive test is equivocal or non-diagnostic 1.
Why This Sequential Approach Makes Sense
Coronary CTA excels at anatomic assessment but has important limitations:
- Severe calcification can make stenosis assessment unreliable 4, 1, 5
- Intermediate stenoses (40-90%) identified on CTA are not necessarily functionally significant—they don't always cause myocardial ischemia 1
- Poor image quality from irregular heart rate, obesity, or inability to breath-hold can render CTA non-diagnostic 1
The anatomic information from CTA doesn't tell you whether a stenosis is causing ischemia. This is where functional testing with agents like Lexiscan becomes critical.
Lexiscan (Regadenoson) as the Stress Agent
Lexiscan is FDA-approved specifically for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress 6. It works as an A2A adenosine receptor agonist that produces coronary vasodilation and increases coronary blood flow 6.
Key advantages for this clinical scenario:
- Single bolus injection (0.4 mg over 10 seconds) rather than continuous infusion 6
- Rapid onset with coronary blood flow increasing to greater than twice baseline by 30 seconds 6
- Short duration of effect, decreasing to less than twice baseline within 10 minutes 6
- Well-tolerated with a known safety profile 6
Research supports this approach: Studies demonstrate that regadenoson stress perfusion imaging (whether SPECT or CT perfusion) can effectively identify functionally significant stenoses, with particular value in clarifying intermediate stenoses found on CTA 7, 8.
The Clinical Algorithm
When faced with an equivocal coronary CTA:
First, determine why the CTA is equivocal:
- Severe coronary calcification obscuring stenosis assessment?
- Intermediate stenosis (40-90%) of uncertain significance?
- Technical factors (motion artifact, poor contrast opacification)?
- Discordance between clinical suspicion and CTA findings?
For intermediate stenoses or uncertain functional significance: Order functional imaging with Lexiscan stress testing (SPECT MPI, stress echocardiography, or stress CMR) 1, 2, 1, 3
For technically inadequate studies: Consider repeat CTA with better preparation OR proceed directly to functional imaging 1
For high-risk patients with severe symptoms despite equivocal CTA: Consider proceeding directly to invasive coronary angiography with FFR capability 1
Important Caveats
Patient preparation is critical: Patients must avoid all methylxanthines (caffeine, theophylline, aminophylline) for at least 12 hours before Lexiscan stress testing, as caffeine can reduce the ability to detect reversible ischemic defects by approximately 60% 6.
Contraindications to Lexiscan include:
- Second- or third-degree AV block without a functioning pacemaker
- Sinus node dysfunction without a pacemaker
- Acute myocardial ischemia or unstable angina 6
Have resuscitation equipment immediately available, as serious adverse events including myocardial infarction, ventricular arrhythmias, and cardiac arrest have been reported, though rare 6, 9.
Alternative to Invasive Angiography
This sequential approach (CTA followed by functional imaging when equivocal) is explicitly preferred over proceeding directly to invasive coronary angiography in most cases. The 2019 ESC guidelines note that ICA with invasive functional evaluation should be considered for confirmation of diagnosis in patients with an uncertain diagnosis on non-invasive testing 1, but functional imaging is typically the next appropriate step unless the patient has high-risk features requiring urgent intervention.
The 2014 ACC/AHA guidelines acknowledge that when stress testing yields an ambiguous or indeterminate result in a patient with high likelihood of CAD, coronary angiography may be preferable to another noninvasive test 10, 11, but this applies more to situations where multiple non-invasive tests have been inconclusive rather than as the immediate next step after an equivocal CTA.
In summary: ordering Lexiscan stress testing after an equivocal coronary CTA is not only appropriate but represents guideline-recommended practice to determine the functional significance of coronary lesions and guide subsequent management decisions.